E kiʻi ʻoe i ka link VIA LIFETIME DOWNLOAD LINK (FAST SPEED) MA hope o ka uku

 ʻO ka hālāwaiʻepekemaʻepekemaʻo HFSA 2019

Nā Kumuhana A me nā Luna ʻlelo:

 1. PM 1 - Ka poʻokela ma ka ʻepekema unuhi
2. SAT 1 - Mitral Regurgitation i ka puʻuwai puʻuwai ʻole 2019 Nā Luʻi a me nā manawa kūpono
3. SAT 2 - Cardiovascular, Metabolic, a me nā hopena Renal ma nā mea maʻi puʻuwai maha-Morbid me nā maʻi diabetes Type 2.
4. SAT 3 - Ka hoʻomaikaʻi ʻana i nā hopena i kāu poʻe maʻi HF me ka mālama ʻana i nā hōʻike e pili ana iā Hyperkalemia
5. PLENARY - Kūʻokoʻa mai ka hoʻomaopopo ʻole i ka puʻuwai, Empathy a me Activism
6. SESSION 1 - Huʻi Cardiogenic Huʻi i ka STEMI Hoʻihoʻi, Myocarditis, a me nā ʻōlelo hōʻino ākea.
7. SESSION 2 - Nā hoʻopaʻapaʻa nui a me nā hoʻopaʻapaʻa o kēia wā ma ʻō o ka Atelanika
8. SESSION 3 - He ʻumi ʻōlelo aʻoaʻo maʻalahi he ʻumi e pale aku ai iā HF
9. SESSION 4 - Prognosis a me nā mālama ʻana no ka HF Advanced Ambatory
10. SESSION 5 - General Cardiology vs Community and Academic HF - E aʻo kāua mai kekahi i kekahi
11. SESSION 6 - He ʻumi mau ʻōlelo aʻoaʻo maʻalahi he ʻumi mau maʻalahi ma ka Cardiogenic Shock
12. SESSION 7 - Rapid Fire Abstract no nā noiʻiʻo kumu
13. SESSION 8 - Nā pilikia i ka mālama ʻana i nā maʻi puʻuwai makua makua PH, RV Failure, Arrhythmia
14. SESSION 9 - He hopena kūpono ʻole ka loli o ke kahu maʻi a me ke olakino pili i waena o ka World Circulate Support World.
15. SESSION 10 - Ke Kula Nui o FDA e kia ana i ka mea hoʻomanawanui i ka noiʻi maʻi a me ka hoʻomohala ʻana i nā lāʻau
16. SAT 4 -ʻO nā ʻōuli nā ʻōkuhi o ka Iceberg Navigating Management o ke kūpikipiki ʻana i ka puʻuwai puʻuwai
17. SAT 5 - Kahi Hoʻokele Kime Hoʻohui i ka Hoʻohui Lapaʻau a me ke Keʻoki ʻana o ka Heart Advanced Failure Optimal Use a me ka hopena o ke Kākoʻo Mīkini Mīkini.
18. SESSION 11 - He ʻumi ʻōlelo aʻoaʻo maʻalahi he ʻumi e hōʻike ana i ka Volume Overload Volume Overload ma ke keʻena maʻi
19. SESSION 12 - 2019 Hoʻohou e pili ana i nā hoʻokolohua hoʻokolohua no nā lāʻau HF e kū mai nei a me nā mea hana lāʻau
20. SESSION 13 - Ke wehewehe ʻana i ka RV Failure Pathophysiology a me nā ʻike kilokilo
21. SESSION 14 - Hāʻawi ʻo JNC Investigator i ka ʻepekema a me ka lāʻau lapaʻau
22. SESSION 15 - Nānā Nānā Nānā Nānā Haumāna & Haumāna1
23. SESSION 16 - He ʻumi mau ʻōlelo aʻoaʻo he ʻumi pehea e hoʻokō pono ai i nā ʻenehana e kōkua ai i ka HF Care a me ka hōʻemi ʻana i nā heluhelu
24. SESSION 17 - Ka Hoʻokaʻawale Ke Alanui ʻōnaehana ma HFpEF Pehea e hoʻomālamalama ai nā ʻano hana
25. Kau 18 - HF ma ka Maʻi Maʻi Ma hope loa o ka pae ʻO kahi Multidisciplinary Approach i kahi pilikia1 hoʻowahāwahā ʻia.
26. SESSION 19 - Nā Dilemmas o kēia wā ma ka LVAD Therapy
27. SESSION 20 - Nā mākau kumu no ka hoʻomaʻamaʻa ʻana o AHFTC
28. SESSION 22 - Nā ʻōnaehana o ka mālama ʻana ma Cardiogenic Shock
29. 2018-2019 Nā Hōʻailona he ʻumi, News & Publication ma HF
30. SESSION 26 - Nā Manaʻo Uku Uku no ka Hoʻoholo Hoʻohālikelike Kūlana. Pehea wau e hālāwai ai me nā mandate hoʻoholo.
31. SESSION 23 - Nā Omics Unuhi i Ka Hewa Maʻi ʻole i ka Hopena Lapaʻau
32. SESSION 25 - Nā Haʻawina i ʻIke ʻia 100 mau makahiki mai nā kahu hānai HF
33 SESSION 27 - International Session Global Challenges a me nā hana ʻoi loa ma HF ākea
34. SESSION 28 - Pehea e hōʻoia ai a hoʻomalu ai i ka Cardiomyopathies Inflammatory Myocarditis Foundation
35. ʻO ka papaʻai, kaʻai & ka hana ʻana o ka cardiac - Mai ka ʻaoʻao a hiki i ka Bench & hoʻi hou
36. SESSION 30 - Clinun Conundrums Pharmacotherapy no ka HFrEF Kūkākūkā hihia
37. SESSION 31 - Pehea e hoʻopili ai i nā Dyads Mālama Hoʻolālā i ka Managing HF
38. SAT 6 - Hoʻemi i ka Cardiovascular a me ka Renal Risk me SGLT2 Inhibitors e ʻimi nei i nā hōʻike
39. SAT 7 - Wahi Honua Hou o ATTR Cardiac Amyloidosis Hōʻalo i nā Pitfalls i ka Diagnosis a me ka mālama ʻana.
40. SESSION 34 - He ʻumi mau ʻōlelo aʻoaʻo a ka Cardiac Amyloidosis - ʻaʻohe lōʻihi o ka hoʻomaʻamaʻa ʻana i ka naʻau, i kēia manawa he Pandemi hiki ke mālama ʻia.
41. Nā hoʻopaʻapaʻa i ka maʻi nui o Cardio-Renal Syndrome - Kūkākūkā a me nā hoʻopaʻapaʻa e pili ana i nā kaua wai
42. SESSION 35 - Pehea e hoʻokele ai i nā pilikia o ka maʻi maʻi maʻi i ka wā o ka hāpai ʻana
43. Nā Conundrums Lapaʻau - Managing AFib & Mea Hana Therapy ma HF - Nā hoʻopaʻapaʻa hoʻopaʻapaʻa hihia
44. SESSION 37 - Kōmike Paipai Kākoʻo The Multidimensional Challenge of Drug Pricing and Preapprovals
45. NĀ KULA 39 - Ka Spectrum o ka mālama no nā mea maʻi me nā Cardiomyopathies Genetic
46. ​​SESSION 38 - Late Breaking Clinical Trials
47. SESSION 40 - He ʻumi mau ʻōlelo aʻoaʻo maʻalahi he XNUMX mau mea maʻi me ka maʻi diabetes a me ka HF
48. SESSION 41 - Ke hoʻohana ʻana i ka Mitral Regurgitation kahi hana hou i nā kaʻina hana lapaʻau
49. SESSION 42 - Nā Papahana i ka Hoʻohana ʻana i nā Therapies Hou
50. SESSION 53 - Late Breaking Clinical Trials and Insights me Angiotensin Receptor Neprilysn Inhibitors
51. SESSION 43 - He ʻumi mau ʻōlelo ʻōlelo aʻoaʻo he ʻumi pehea e hoʻomaikaʻi maikaʻi ai i ka nui o ka nui o ka Volume HF
52. SESSION 44 - ʻike hou i ka Cardio-Oncology
53. SESSION 45 - Ka hoʻomaopopo ʻana i ka pilina o ka puʻuwai-puʻuwai i nā ʻike hou i ka hōʻino ʻia o ka ʻike a me ka hanu ʻana o ka hiamoe ʻole.
54. SESSION 46 - Ke Kaʻina Hoʻohuli Huli Hou
55. SESSION 47 - Ka Hoʻololi Hoʻololi Hoʻololi Hoʻololi Hoʻolaha o nā Lapaʻau mālama a me Optimization
56. SESSION 54 - Hoʻomaopopo HF ma ʻAmelika ʻAmelika
57. SESSION 48 - HYDE PARK
58. SESSION 49 - Ke kamaʻilio nei i ka hakina ʻeneki i loaʻa hou ka naʻau ʻole
59. SESSION 50 - He ʻumi mau ʻōlelo aʻoaʻo he ʻumi e mālama ana i nā mea maʻi ma waena o ka Spectrum o ka pulmonary hypertension
60. SESSION 51 - Ke Kālā Psychosocial o ka mea hoʻomanawanui HF kiʻekiʻe
61. SESSION 52 - Ke aʻo ʻana i nā ʻōnaehana olakino, hōʻike hōʻike honua maoli a me HF Hype a i ʻole ʻoiaʻiʻo